Evaluation of Soft Multifocal Lenses in Presbyopic Previous Contact Lens Wearers

April 1, 2024 updated by: Jennifer Fogt
To explore the wear experience in Dailies TOTAL1 Multifocal contact lenses in presbyopic adults who have previously dropped out of contact lens wear.

Study Overview

Status

Recruiting

Conditions

Detailed Description

The purpose of this study is to evaluate the wear experience of people with presbyopia who previously dropped out of contact lens wear when fit with a Delefilcon A soft lens multifocal lens. Investigators expect to enroll a relatively equal amount of former soft multifocal contact lens wearers who dropped out due to poor vision at distance or near and single vision wearers who dropped out due to poor near vision. The key endpoints include Visual Analog Scale survey of lens wear symptoms (comfort, dryness, vision) with contact lenses and assessment of the participant's quality of life with the Dailies TOTAL1 Multifocal® contact lenses.

Study Type

Interventional

Enrollment (Estimated)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Jennifer Fogt, OD, MS

Study Locations

    • Ohio
      • Columbus, Ohio, United States, 43210
        • Recruiting
        • The Ohio State University College of Optometry
        • Contact:
        • Contact:
          • Jennifer Fogt, OD, MS
      • Granville, Ohio, United States, 43023

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Ability to give informed consent.
  • Any gender.
  • Any racial or ethnic origin.
  • At least 38 years of age or older.
  • Willing to spend time for the study. Three visits are required to complete the study, and additional follow up visits could be scheduled if needed.
  • Subjects must have corrected distance visual acuity in both eyes equivalent to 20/25 or better at the screening visit.
  • Spectacle sphere power range between +6.00 to -10.00.
  • Previously dropped out of contact lens wear due to vision or vision and discomfort.
  • Good general health (defined by medication use that has not changed within the last month and the absence of medical conditions or treatments that are deemed confounding to the data as determined by the PI

Exclusion Criteria:

  • Current or active ocular inflammation or infection as determined by the Investigator.
  • Astigmatism ≥ 1.00 D in either eye.
  • History of previous eye surgery.
  • Strabismus or binocular vision abnormalities that prevent completion of testing, at the discretion of the Investigator.
  • Demonstration or history of corneal ectasia or keratoconus.
  • Pregnant or lactating

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Lens wear experience
Subject will wear contact lenses for about a month during the day.
Daily disposable multifocal soft contact lens that will be worn for 1 month.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual Analog Scale
Time Frame: 1 month
Visual Analog Scale survey of lens wear symptoms (comfort, dryness, vision) with contact lenses
1 month
Quality of Life Survey
Time Frame: 1 month
Assessment of the participant's quality of life with the daily disposable multifocal contact lenses
1 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Collaborators

Investigators

  • Principal Investigator: Jennifer Fogt, OD, MS, Ohio State University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 6, 2023

Primary Completion (Estimated)

July 31, 2024

Study Completion (Estimated)

September 1, 2024

Study Registration Dates

First Submitted

September 12, 2023

First Submitted That Met QC Criteria

September 12, 2023

First Posted (Actual)

September 25, 2023

Study Record Updates

Last Update Posted (Actual)

April 2, 2024

Last Update Submitted That Met QC Criteria

April 1, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2023H0245

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Presbyopia

Clinical Trials on Daily disposable multifocal soft contact lens

3
Subscribe